StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
HURA

TuHURA Biosciences, Inc.

HURA Nasdaq Pharmaceutical Preparations EDGAR ↗
$2.14
-0.03 -1.38%

Key statistics

from XBRL data in SEC filings
Market cap
$136M
Revenue (TTM)
$0.00
Net income (TTM)
-$31.9M
EPS (TTM)
$-0.61
P/E ratio
Dividend yield
Free cash flow
-$27.7M
Cash
$6.30M
Total assets
$29.7M
Gross margin
52-week range
$0.41 – $3.90

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Took on a direct financial obligation Jul 29, 2026 8-K Took on a direct financial obligation Jul 7, 2026 8-K Item 5.08 Jun 17, 2026 8-K Took on a direct financial obligation May 29, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2026 8-K/A Other events Apr 30, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Apr 22, 2026 8-K Director or officer change; Other events Apr 8, 2026 8-K Results of operations (earnings release) Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Delisting notice or listing-rule failure Jan 30, 2026 8-K Entered a material agreement; Other events Dec 10, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 5, 2025 8-K Regulation FD disclosure Nov 25, 2025 8-K Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Entered a material agreement Nov 4, 2025 8-K Other events Nov 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation Oct 31, 2025 8-K Entered a material agreement Sep 11, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K/A Aug 12, 2025 8-K Completed an acquisition or disposition; Regulation FD disclosure Jun 30, 2025 8-K Amended charter or bylaws Jun 27, 2025 8-K Shareholder vote results; Regulation FD disclosure Jun 24, 2025 8-K Jun 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K/A Director or officer change May 7, 2025 8-K Entered a material agreement; Director or officer change May 7, 2025 8-K Results of operations (earnings release) Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Regulation FD disclosure Mar 18, 2025 8-K Director or officer change; Regulation FD disclosure Mar 12, 2025 8-K Entered a material agreement Feb 14, 2025